Business Context and Reporting Period
This Form 8-K was filed by Enochian BioSciences Inc. (not Lunai Bioworks Inc.) on December 1, 2021. The filing serves as a Regulation FD disclosure regarding a corporate presentation made available at the World Vaccine & Immunotherapy Congress.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a presentation and does not contain audited financial statements or quarterly results.
Material Changes
No material financial changes versus a prior period are reported in this document. The filing solely announces the availability of a corporate presentation (Exhibit 99.1).
Guidance, Outlook, and Risks
- Management Commentary: The company made a corporate presentation available to the public. The content of this presentation is attached as Exhibit 99.1.
- Forward-Looking Statements: The filing explicitly states that the information in the presentation shall not be deemed filed for purposes of Section 18 of the Exchange Act.
- Update Obligation: The Company undertakes no duty or obligation to update or revise information included in this Report or the Exhibit.
Key Facts for Investor Verification
- Verify the actual content of the Corporate Presentation (Exhibit 99.1) for any specific operational updates or scientific data, as the 8-K text itself contains no such details.
- Confirm the registrant name is Enochian BioSciences Inc. (Ticker: ENOB), noting a discrepancy with the requested company name "Lunai Bioworks Inc."
- Note that the presentation materials are not subject to the liabilities of Section 18 of the Exchange Act and are not considered "filed" for that purpose.